Envestnet Asset Management
CELGZ

Envestnet Asset Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Envestnet Asset Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed – – 3248
2016
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 3486

Other funds holding CELGZ

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MSTVIM
Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Envestnet Asset Management's CELGZ Position: Q1 2017 in Review

Envestnet Asset Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2017, closing a stake of 1 share.

Envestnet Asset Management first reported a position in CELGZ in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 22 funds tracked by Wall St. Rank hold CELGZ as of Q1 2017.

  • Envestnet Asset Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
  • Envestnet Asset Management sold 1 Celgene Corporation Contingent Value Rights share in Q1 2017.
  • Envestnet Asset Management first reported a position in Celgene Corporation Contingent Value Rights in Q4 2016 and held it in 1 quarter.
  • Envestnet Asset Management's Celgene Corporation Contingent Value Rights position peaked at $0 in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2017.

Based on Envestnet Asset Management's 13F filing for Q1 2017, filed 9 May 2017.